{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T20:58:29Z","timestamp":1791406709469,"version":"4.3.3"},"reference-count":24,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,1]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>\n                                 <jats:italic toggle=\"yes\">Candida<\/jats:italic> species are the most common cause of invasive fungal disease, and children with hematologic malignancy are at increased risk. Non-<jats:italic toggle=\"yes\">albicans Candida<\/jats:italic> (NAC) now account for more than half of all invasive candidiasis (IC) and carry a worse prognosis. We aimed to compare the epidemiology, risk factors, organ dissemination, biomarkers and outcomes in IC based on the species implicated and evaluate trends in antifungal resistance over time.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>Patients 0\u201318 years of age with hematologic malignancy and IC at 2 centers were included. Fifty-three patients from 2011 to 2022 were identified. Information related to demographics, host and risk factors, <jats:italic toggle=\"yes\">Candida<\/jats:italic> species and antifungal susceptibilities, treatment and outcomes was collected via retrospective chart review. Data were analyzed at the species level.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>The incidence rate of IC was 29 per 1000 patients with leukemia and lymphoma. The median time to infection from diagnosis of malignancy was 38 days. <jats:italic toggle=\"yes\">Candida tropicalis<\/jats:italic> (n = 17; 30%) was the most identified species followed by <jats:italic toggle=\"yes\">Candida albicans<\/jats:italic> (n = 14; 25%). Patients with <jats:italic toggle=\"yes\">C. tropicalis<\/jats:italic> infection were more likely to have dissemination to the eyes (<jats:italic toggle=\"yes\">P<\/jats:italic> = 0.035), spleen (<jats:italic toggle=\"yes\">P<\/jats:italic> = 0.001) and skin (<jats:italic toggle=\"yes\">P<\/jats:italic> = 0.003) than patients with <jats:italic toggle=\"yes\">C. albicans<\/jats:italic> or other NAC. Of the 34 patients who underwent dilated retinal examination, 24% (n = 8) had evidence of intraocular candidiasis. Seven of the 8 patients with intraocular disease had prolonged candidemia (3 or more days; <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.003). The 12-week crude mortality rate was 16.9%.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>NAC, specifically <jats:italic toggle=\"yes\">C. tropicalis<\/jats:italic>, accounted for most of the IC in children with hematological malignancies. Screening for intraocular candidiasis continues to play an important role in patients with IC, and future studies are needed to determine if screening can be limited to patients with select risk factors.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/inf.0000000000004502","type":"journal-article","created":{"date-parts":[[2024,10,9]],"date-time":"2024-10-09T19:04:28Z","timestamp":1728500668000},"page":"58-63","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":8,"title":["Invasive Candidiasis in Pediatric Hematologic Malignancy: Increased Risk of Dissemination With Candida tropicalis"],"prefix":"10.1097","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-9106-6119","authenticated-orcid":false,"given":"Amira M.","family":"Said","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Section of Pediatric Infectious Diseases, Baylor College of Medicine and Texas Children\u2019s Hospital, Houston, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faraz","family":"Afridi","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Infection Control and Employee Health, Division of Internal Medicine, The University of Texas MD Anderson Cancer, Houston, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele S.","family":"Redell","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Cancer and Hematology Center, Baylor College of Medicine and Texas Children\u2019s Hospital, Houston, Texas."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chelsea","family":"Vrana","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Cancer and Hematology Center, Baylor College of Medicine and Texas Children\u2019s Hospital, Houston, Texas."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Candelaria","family":"O\u2019Farrell","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Cancer and Hematology Center, Baylor College of Medicine and Texas Children\u2019s Hospital, Houston, Texas."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael E.","family":"Scheurer","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Cancer and Hematology Center, Baylor College of Medicine and Texas Children\u2019s Hospital, Houston, Texas."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie J.","family":"Dailey Garnes","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Infection Control and Employee Health, Division of Internal Medicine, The University of Texas MD Anderson Cancer, Houston, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Monica","family":"Gramatges","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Cancer and Hematology Center, Baylor College of Medicine and Texas Children\u2019s Hospital, Houston, Texas."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ankhi","family":"Dutta","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Section of Pediatric Infectious Diseases, Baylor College of Medicine and Texas Children\u2019s Hospital, Houston, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,10,2]]},"reference":[{"key":"R1-20250131","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1086\/673988","article-title":"Incidence, classification, and risk stratification for Candida central line\u2013associated bloodstream infections in pediatric patients at a tertiary care children\u2019s hospital, 2000\u20132010.","volume":"34","author":"Klatte","year":"2013","journal-title":"Infect Control Hosp Epidemiol"},{"key":"R2-20250131","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1097\/01.inf.0000078159.53132.40","article-title":"Nosocomial bloodstream infections in pediatric patients in United States hospitals: epidemiology, clinical features and susceptibilities.","volume":"22","author":"Wisplinghoff","year":"2003","journal-title":"Pediatr Infect Dis J"},{"key":"R3-20250131","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1056\/NEJMra1315399","article-title":"Invasive candidiasis.","volume":"373","author":"Kullberg","year":"2015","journal-title":"N Engl J Med"},{"key":"R4-20250131","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1093\/jpids\/piad057","article-title":"Adjunctive diagnostic studies completed following detection of candidemia in children: secondary analysis of observed practice from a multicenter cohort study conducted by the pediatric fungal network.","volume":"12","author":"Wattier","year":"2023","journal-title":"J Pediatric Infect Dis Soc"},{"key":"R5-20250131","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1093\/jpids\/pix046","article-title":"Epidemiology of invasive fungal disease in children.","volume":"6","author":"Pana","year":"2017","journal-title":"J Pediatric Infect Dis Soc"},{"key":"R6-20250131","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1097\/01.mph.0000155861.38641.ca","article-title":"Invasive fungal infections in pediatric oncology patients: 11-year experience at a single institution.","volume":"27","author":"Rosen","year":"2005","journal-title":"J Pediatr Hematol Oncol"},{"key":"R7-20250131","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1002\/pbc.23005","article-title":"Invasive fungal infections in pediatric oncology.","volume":"56","author":"Mor","year":"2011","journal-title":"Pediatr Blood Cancer"},{"key":"R8-20250131","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1086\/496922","article-title":"The epidemiology and attributable outcomes of candidemia in adults and children hospitalized in the United States: a propensity analysis.","volume":"41","author":"Zaoutis","year":"2005","journal-title":"Clin Infect Dis"},{"key":"R9-20250131","doi-asserted-by":"crossref","first-page":"S79","DOI":"10.1093\/ofid\/ofy358","article-title":"Twenty years of the SENTRY antifungal surveillance program: results for Candida species from 1997-2016.","volume":"6","author":"Pfaller","year":"2019","journal-title":"Open Forum Infect Dis"},{"key":"R10-20250131","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.diagmicrobio.2019.05.017","article-title":"Poor prognosis of Candida tropicalis among non-albicans candidemia: a retrospective multicenter cohort study, Korea.","volume":"95","author":"Ko","year":"2019","journal-title":"Diagn Microbiol Infect Dis"},{"key":"R11-20250131","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.jinf.2015.05.009","article-title":"Candida tropicalis bloodstream infection: incidence, risk factors and outcome in a population-based surveillance.","volume":"71","author":"Fern\u00e1ndez-Ruiz","year":"2015","journal-title":"J Infect"},{"key":"R12-20250131","doi-asserted-by":"crossref","first-page":"3205","DOI":"10.1200\/JCO.20.00158","article-title":"Clinical practice guideline for systemic antifungal prophylaxis in pediatric patients with cancer and hematopoietic stem-cell transplantation recipients.","volume":"38","author":"Lehrnbecher","year":"2020","journal-title":"J Clin Oncol"},{"key":"R13-20250131","doi-asserted-by":"crossref","first-page":"e643","DOI":"10.1097\/MPH.0000000000002197","article-title":"Evaluation for metastatic Candida focus and mortality at Candida-associated catheter-related bloodstream infections at the pediatric hematology-oncology patients.","volume":"44","author":"Duzgol","year":"2022","journal-title":"J Pediatr Hematol Oncol"},{"key":"R14-20250131","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1086\/599039","article-title":"Epidemiology and outcomes of candidemia in 2019 patients: data from the Prospective Antifungal Therapy Alliance registry.","volume":"48","author":"Horn","year":"2009","journal-title":"Clin Infect Dis"},{"key":"R15-20250131","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1093\/cid\/ciz1008","article-title":"Revision and update of the consensus definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer and the mycoses study group education and research consortium.","volume":"71","author":"Donnelly","year":"2020","journal-title":"Clin Infect Dis"},{"key":"R16-20250131","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1086\/590566","article-title":"Defining responses to therapy and study outcomes in clinical trials of invasive fungal diseases: mycoses study group and European Organization for Research and Treatment of Cancer consensus criteria.","volume":"47","author":"Segal","year":"2008","journal-title":"Clin Infect Dis"},{"key":"R17-20250131","doi-asserted-by":"crossref","first-page":"e29228","DOI":"10.1002\/pbc.29228","article-title":"An evidence-based, risk-adapted algorithm for antifungal prophylaxis reduces risk for invasive mold infections in children with hematologic malignancies.","volume":"68","author":"Dutta","year":"2021","journal-title":"Pediatr Blood Cancer"},{"key":"R18-20250131","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/civ933","article-title":"Clinical practice guideline for the management of candidiasis: 2016 update by the infectious diseases society of America.","volume":"62","author":"Pappas","year":"2016","journal-title":"Clin Infect Dis"},{"key":"R19-20250131","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1097\/INF.0b013e318213da0f","article-title":"Candida non-albicans versus Candida albicans fungemia in the non-neonatal pediatric population.","volume":"30","author":"Dutta","year":"2011","journal-title":"Pediatr Infect Dis J"},{"key":"R20-20250131","doi-asserted-by":"crossref","first-page":"369","DOI":"10.3109\/10428199309148562","article-title":"Candida tropicalis infections in children with leukemia.","volume":"10","author":"Flynn","year":"1993","journal-title":"Leuk Lymphoma"},{"key":"R21-20250131","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1002\/1097-0142(19910801)68:3<594::AID-CNCR2820680325>3.0.CO;2-0","article-title":"Candida tropicalis and Candida albicans fungemia in children with leukemia.","volume":"68","author":"Marina","year":"1991","journal-title":"Cancer"},{"key":"R22-20250131","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1097\/INF.0000000000003082","article-title":"Candidemia in children: a 16-year longitudinal epidemiologic study.","volume":"40","author":"Silvester","year":"2021","journal-title":"Pediatr Infect Dis J"},{"key":"R23-20250131","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/1469-0691.12039","article-title":"ESCMID guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients.","volume":"18","author":"Cornely","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"R24-20250131","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ophtha.2021.07.015","article-title":"American Academy of Ophthalmology recommendations on screening for endogenous Candida endophthalmitis.","volume":"129","author":"Breazzano","year":"2022","journal-title":"Ophthalmology"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000004502","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T13:01:11Z","timestamp":1738328471000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000004502"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,2]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000004502","relation":{},"ISSN":["0891-3668","1532-0987"],"issn-type":[{"value":"0891-3668","type":"print"},{"value":"1532-0987","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,2]]}}}